期刊文献+

海藻酸钠-多聚赖氨酸-海藻酸钠微囊对骨髓间充质干细胞生长分化性状的影响 被引量:1

The effect of APA microcapsule on MSCs growth and differentiation
原文传递
导出
摘要 目的探讨运用海藻酸钠-多聚赖氨酸-海藻酸钠(APA)微囊化免疫隔离技术对骨髓间充质干细胞(MSCs)生长分化的影响。方法采用脉冲式高压静电微囊制备仪制备出APA-MSCs微囊复合体,在成囊后第1天和第4天运用荧光素双醋酸酯/溴化乙锭(FDA/EB)染色确定MSCs成活率。采用离心破囊方法破囊,培养并观察破囊后MSCs形态和成骨作用等。结果微囊化后细胞在其内存活率约70%~80%;破囊后的细胞有活跃的增殖能力,经茜素红染色证实具有成骨潜力。结论MSCs在APA微囊内生长良好,保持干细胞特有生长分化,APA微囊可用于对MSCs进行免疫隔离。 Objective To study the effect of sodium alginate-poly-L-lysine-sodium alginate (APA) microencapsulated immunoisolation technology on the growth characteristic and differentiation of bone marrow-derived mesenchymal stem cells ( MSCs ). Methods The APA-MSCs was made by the pulsed high-voltage electrostatic microcapsule instrument. The MSCs' Survival rate in the APA microcapsule was determined by the fluorescein diacetate/thidium bromide (FDA/EB) double staining. The capsules were broken by the centrifuge. And then the MSCs were ellected, cultured' and observed their shape and potential of bone formation. Results The survival rate of the MSCs in APA mieroeapsule was about 70% - 80%. The MSCs out of APA microcapsule showed active proliferation capacity in vitro and its bone formation potential was confirmed by alizarin red staining. Conclusions The MSCs has a good survival in APA microcapsules. Their differentiation is maintained. APA mierocapsule could he used for immunoisolation of MSCs.
出处 《中华关节外科杂志(电子版)》 CAS 2010年第1期47-49,共3页 Chinese Journal of Joint Surgery(Electronic Edition)
基金 广东省自然科学基金项目(06022696)
关键词 骨髓间充质干细胞 细胞分化 微囊藻属 Bone marrow-derived mesenchymal stem cells Cell differentiation Microcystis
  • 相关文献

参考文献11

二级参考文献33

  • 1马小军,解玉冰,周丽,虞星炬,袁权,李昌臣,郝莉,贺欣,孙绵方.APA生物微胶囊的制备条件与膜强度的关系[J].中华器官移植杂志,1995,16(4):156-157. 被引量:14
  • 2丁惠锋,汤亭亭.微胶囊技术及其在骨科领域的应用[J].中国修复重建外科杂志,2005,19(12):1029-1032. 被引量:5
  • 3刘荣,李保国,丁惠锋,汤亭亭.转BMP-2基因MSCs细胞微囊制备的影响因素[J].中国医药工业杂志,2005,36(12):757-759. 被引量:2
  • 4[1]Yoo JU, Barthel TS, Nishimura K, Solchaga L, Caplan AI, Goldberg VM, Johnstone B. The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells[J]. J Bone Joint Surg, 1998;80A(12):1745-1757.
  • 5[2]Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow[J]. Bone,1992;13(1):81-88.
  • 6[3]Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro[J]. J Cell Biochem, 1997;64(2):295-312.
  • 7[4]Shibano K, Watanabe J, Iwamoto M, Ogawa R, Kanamura S. Culture of stromal cells derived from medullary cavity of human long bone in the presence of 1,25-dihydroxyvitamin D3, recombinant human bone morphogenetic protein-2, or ipriflavone[J]. Bone, 1998;22(3):251-258.
  • 8[5]Caplan AI. Mesenchymal stem cells[J]. J Orthop Res, 1991;9(5):641-650.
  • 9[6]Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy[J]. J Cell Biochem, 1994;56(3):283-294.
  • 10[7]Vunjak Novakovic G,Obradovic B,Martin I, Bursac PM, Langer R, Freed LE. Dynamic cell seeding of polymer scaffolds for cartilage tissue engineering[J]. Biotechnol Prog,1998;14(2):193-202.

共引文献60

同被引文献12

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部